Medifast Q1 2025: revenue down 34% to $115.7M, net loss $0.8M; Q2 guidance weak

MEDIFAST INC

2025-Q1 EPS reported -$0.07 revenue$115,728,000

Revenue fell 33.8% to $115.7M; active earning coaches down 32.8% to 25,400.
Net loss of $0.8M vs. net income of $8.3M a year ago; diluted EPS -$0.07.
Gross margin held at 72.8%; operating loss $1.3M vs. operating income $7.9M.
Q2 2025 revenue guidance $85M-$105M; loss per share $0.00-$0.55.
Cash, equivalents, and investments $164.6M; no debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.